凝固分析装置の市場規模、シェア、成長分析：製品別、検査別、技術別、エンドユーザー別、地域別 - 産業予測 2025～2032年

凝固分析装置の世界市場規模は2023年に42億米ドルと評価され、2024年の44億4,000万米ドルから2032年には69億8,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは5.8％で成長する見通しです。

世界の凝固分析装置市場は、血液凝固障害と心血管疾患の有病率の上昇に後押しされて力強い成長を遂げています。これらの分析装置は、抗凝固療法の効果的なモニタリングと管理において重要な役割を果たしています。市場拡大の主な要因としては、より迅速で正確な結果を得るための技術的進歩や、ヘルスケア支出の増加などが挙げられます。また、大手企業が患者の予後改善を目的とした革新的なソリューションを導入していることから、携帯可能で使い勝手の良い機器に対する需要も高まっています。しかし、価格圧力や厳しい規制の枠組みといった課題は依然として残っています。北米と欧州が引き続き市場シェアをリードする一方、アジア太平洋地域が有望な成長地域として浮上しています。全体として、効率的な凝固モニタリングソリューションに対するニーズの高まりに後押しされ、市場の見通しは引き続き明るいです。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制分析

凝固分析装置市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 臨床検査分析装置
  • 消耗品
  • 試薬
  • 標準管理校正
  • システム
  • 自動化システム
  • 半自動システム
  • 手動システム
• ポイントオブケア検査分析装置

凝固分析装置市場規模：検査別& CAGR（2025-2032）

• 市場概要
• プロトロンビン時間検査
• Dダイマー検査
• フィブリノーゲン検査
• 活性化凝固時間検査
• 活性化部分トロンボプラスチン時間検査
• 血小板機能検査
• 抗XA因子検査
• ACT用ヘパリンおよびプロタミン用量反応試験
• その他の凝固検査

凝固分析装置市場規模：技術別& CAGR（2025-2032）

• 市場概要
• 光学技術
• 機械技術
• 電気化学技術
• その他の技術

凝固分析装置市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 臨床検査室
• その他のエンドユーザー

凝固分析装置市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Roche Diagnostics（Switzerland）
• Siemens Healthineers（Germany）
• Abbott Laboratories（United States）
• Sysmex Corporation（Japan）
• Thermo Fisher Scientific（United States）
• Instrumentation Laboratory（IL）（United States）
• Helena Laboratories（United States）
• Nihon Kohden（Japan）
• Diagnostica Stago（France）
• Werfen（Spain）
• Grifols（Spain）
• International Technidyne Corporation（ITC）（United States）
• HemoSonics（United States）
• Randox Laboratories（United Kingdom）
• Helena Point of Care（United States）
• Medtronic（Ireland）
• EKF Diagnostics（United Kingdom）

結論と提言

Global Coagulation Analyzer Market size was valued at USD 4.2 billion in 2023 and is poised to grow from USD 4.44 billion in 2024 to USD 6.98 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).

The global coagulation analyzer market is experiencing robust growth, propelled by the increasing prevalence of clotting disorders and cardiovascular diseases. These analyzers play a vital role in the effective monitoring and management of anticoagulant therapies. Key factors fueling market expansion include technological advancements that facilitate faster, more precise results and rising healthcare expenditures. The demand for portable, user-friendly devices is also on the rise, as major players introduce innovative solutions aimed at improving patient outcomes. However, challenges such as pricing pressures and stringent regulatory frameworks persist. While North America and Europe continue to lead in market share, the Asia-Pacific region is emerging as a promising growth area. Overall, the market outlook remains positive, driven by the escalating need for efficient coagulation monitoring solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Coagulation Analyzer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Coagulation Analyzer Market Segments Analysis

Global Coagulation Analyzer Market is segmented by Product, Test, Technology, End User and region. Based on Product, the market is segmented into Clinical Laboratory Analyzers and Point-Of-Care Testing Analyzers. Based on Test, the market is segmented into Prothrombin Time Testing, D-Dimer Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, Platelet Function Tests, Anti-Factor XA Tests, Heparin & Protamine Dose Response Tests for Act and Other Coagulation Tests. Based on Technology, the market is segmented into Optical Technology, Mechanical Technology, Electrochemical Technology and Other Technologies. Based on End User, the market is segmented into Hospitals, Clinical Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Coagulation Analyzer Market

The aging global population is contributing to a heightened prevalence of several medical conditions, particularly coagulation disorders. As the number of elderly individuals rises, there will be a corresponding surge in the need for coagulation analyzers that facilitate the diagnosis and management of clotting issues like deep vein thrombosis (DVT) and hemophilia. This increased demand is driven by the urgent requirement for efficient monitoring and treatment solutions to address these disorders effectively, which positions the global coagulation analyzer market for significant growth in response to the healthcare needs of an aging demographic.

Restraints in the Global Coagulation Analyzer Market

The Global Coagulation Analyzer market faces significant restraints due to the high costs associated with purchasing and maintaining these devices. Smaller healthcare facilities and those in resource-limited areas often struggle with the substantial initial investment required along with ongoing expenses for maintenance, reagents, and regular calibration. These financial challenges can create barriers to acquiring advanced coagulation analyzers, limiting access to essential diagnostic tools and potentially impacting the quality of patient care in these regions. As a result, the economic constraints hinder the widespread adoption and utilization of coagulation analyzers worldwide.

Market Trends of the Global Coagulation Analyzer Market

The Global Coagulation Analyzer market is experiencing a significant shift due to technological advancements and increased automation, which are revolutionizing laboratory practices. Manufacturers are prioritizing the development of analyzers characterized by superior accuracy, efficiency, and intuitive user interfaces. Innovations such as barcode scanning, automated sample loading, and seamless integration with laboratory information systems are gaining traction, ultimately streamlining testing processes and mitigating human errors. This trend not only enhances laboratory productivity but also aligns with the growing demand for rapid and reliable diagnostic solutions in healthcare settings. As a result, the market is poised for robust growth as facilities adopt these advanced technologies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Analysis

Global Coagulation Analyzer Market Size by Product & CAGR (2025-2032)

• Market Overview
• Clinical Laboratory Analyzers
  • Consumables
  • Reagents
  • Standards, Controls, and Calibrations
  • Systems
  • Automated systems
  • Semi-automated systems
  • Manual systems
• Point-Of-Care Testing Analyzers

Global Coagulation Analyzer Market Size by Test & CAGR (2025-2032)

• Market Overview
• Prothrombin Time Testing
• D-Dimer Testing
• Fibrinogen Testing
• Activated Clotting Time Testing
• Activated Partial Thromboplastin Time Testing
• Platelet Function Tests
• Anti-Factor XA Tests
• Heparin & Protamine Dose Response Tests for Act
• Other Coagulation Tests

Global Coagulation Analyzer Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Optical Technology
• Mechanical Technology
• Electrochemical Technology
• Other Technologies

Global Coagulation Analyzer Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinical Laboratories
• Other End Users

Global Coagulation Analyzer Market Size & CAGR (2025-2032)

• North America (Product, Test, Technology, End User)
  • US
  • Canada
• Europe (Product, Test, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Test, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Test, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Test, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Instrumentation Laboratory (IL) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diagnostica Stago (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Werfen (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Technidyne Corporation (ITC) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HemoSonics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Point of Care (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations